Table 2.
Glycemic control, insulin parameters and β-cell function in all obese subjects before and after the program.
| All subjects (n = 72) | Before | After | Δ | ANOVA P-value |
|---|---|---|---|---|
| FPG (mmol/L) | 5.5 ± 0.9 | 5.2 ± 0.6 | − 0.31 ± 0.64 | < 0.0001 |
| HbA1c (%) | 5.72 ± 0.55 | 5.69 ± 0.39 | − 0.03 ± 0.34 | 0.448 |
| Insulin (pmol/L) | 98 ± 57 | 82 ± 43 | − 16 ± 44 | 0.003 |
| HOMA-IR | 3.6 ± 2.5 | 2.8 ± 1.6 | − 0.8 ± 2.0 | 0.0008 |
| HOMA-β (%) | 149 ± 78 | 144 ± 75 | − 5 ± 71 | 0.58 |
FPG: fasting plasma glucose, HOMA-β: Homeostasis Model Assessment for β-cell function, HOMA-IR: Homeostasis Model Assessment for insulin resistance.
Study conducted at the EPIC Center of the Montreal Heart Institute (2009–2012).